login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
SEMPER PARATUS ACQU -CW26 (TVGNW) Stock News
NASDAQ:TVGNW - Nasdaq -
- Currency: USD
0.0688
0 (-1.57%)
Summary
Stock Chart
Technical Analysis
News
TVGNW Latest News, Press Relases and Analysis
All
Press Releases
5 hours ago - By: Tevogen Bio Inc
- Mentions:
TVGN
MSFT
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
5 hours ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
10 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
MSFT
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
10 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
11 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
11 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
12 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
MSFT
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
12 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
14 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
14 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
MSFT
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
18 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
18 days ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
a month ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters
a month ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters
a month ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
a month ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
2 months ago - By: Yahoo Finance
- Mentions:
IPWR
UPS
FTV
TVGN
...
EXCLUSIVE: Ideal Power Taps Kaimei Electronic To Distribute Products Across Asia
2 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
2 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
2 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
MSFT
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
2 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
2 months ago - By: Yahoo Finance
- Mentions:
TVGN
Tevogen Peports Plans to Increase the Target Population for TVGN 489
2 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow
2 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow
2 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting
2 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting
3 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
3 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
3 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
3 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
3 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
3 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
3 months ago - By: Yahoo Finance
- Mentions:
PRQR
BBIO
TVGN
ATRC
...
ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald
3 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
3 months ago - By: Tevogen Bio Inc
- Mentions:
TVGN
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
Please enable JavaScript to continue using this application.